1Clinical Research Center, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA
2EndoCeutics Inc, Quebec City, QC, Canada
3Clinique de Recherche en Santé des Femmes, Quebec City, QC, Canada
4Columbus Center for Women's Health Research, Columbus, OH
5Medical Center for Clinical Research, San Diego, CA
6Veristat Inc, Holliston, MA.
Address correspondence to: Fernand Labrie, MD, PhD, EndoCeutics, Suite 500, 2975 Laurier Boulevard, Quebec City, Quebec, Canada G1 V 4M7. E-mail: [email protected]
Received 10 October, 2014
Revised 17 December, 2014
Accepted 17 December, 2014
Participating members of the VVA Prasterone Group: Aqua, Keith (Boyton Beach, FL); Archer, David F. (Norfolk, VA); Ayotte, Normand (Shawinigan, QC, Canada); Bachmann, Gloria (New Brunswick, NJ); Baron, Mira (Cleveland, OH); Beyer, Roger (Kalamazoo, MI); Blank, Steven (Sandy Spring, GA); Blouin, François (St-Romuald, QC, Canada); Bouchard, Céline (Quebec, QC, Canada); Cusan, Leonello (Quebec, QC, Canada); Giguère, Nicole (Drummondville, QC, Canada); Girard, Ginette (Sherbrooke, QC, Canada); Goldberg, Cynthia (Tucson, AZ); Goldstein, Irwin (San Diego, CA); Goldstein, Steven (New York, NY); Hauck, Brian (Calgary, AB, Canada); Kaunitz, Andrew (Jacksonville, FL); Khaled, Abdelmoula (Montreal, QC, Canada); Kirstein, Judith (West Jordan, UT); Koltun, William (San Diego, CA); Levine, Bruce (Moorestown, NJ); Lukes, Andrea (Durham, NC); Pinkerton, Joann (Charlottesville, VA); Portman, David J. (Columbus, OH); Swanson, Stephen (Lincoln, NE); Turner, Mark (Meridian, ID); Varano, Susann (Milford, CT); Wade, Anthony (Bathurst, NB, Canada); Waldbaum, Arthur (Denver, CO); Young, Douglas (Sacramento, CA).
Funding/support: This research was sponsored by EndoCeutics.
Financial disclosure/conflicts of interest: F.L. is president and chief executive officer of EndoCeutics. D.F.A. is a consultant to EndoCeutics and has received grants for clinical studies.
